Will the meeting please come to order? I'd like to welcome all of you to the 2026 Annual Meeting of Stockholders of Organogenesis Holdings Inc. I am Gary Gillheeney, President, CEO, and Chair of the Board of Directors of the company. For the past few years, we've successfully conducted our stockholder meetings virtually. Like many companies, we've decided to have a virtual meeting again this year. We will conduct the business of our meeting first and answer any questions after the formal business meeting has concluded. Though we may not be able to answer every question, we will do our best to provide a response to as many as possible. Before we begin, I would like to introduce the other members of the company's board of directors and management team, several of whom are attending our meeting virtually today. Board members Robert Ades, Michael Driscoll, Prathyusha Duraibabu, Jon Giacomin, Michele Korfin, Arthur Leibowitz, Garrett Lustig, Glenn H. Nussdorf, and Gilberto Quintero. Members of the company's management team, Patrick Bilbo, Chief Operating Officer, Robert Cavorsi, Chief Business Officer, David Francisco, Chief Financial Officer, Lori Freedman, Chief Administrative and Legal Officer, Brian Grow, Chief Commercial Officer, and Antonio Montecalvo, Vice President, Health Policy. Also with us today is William Kolb, who is the company secretary and a partner at Foley Hoag LLP, our corporate counsel. The board of directors fixed April 23rd, 2026, as the record date for this meeting. If you were a shareholder of record at the close of business on that date, you're entitled to vote at this meeting. Stockholders who have filed proxies with the company need not take any further action for their votes to be counted. All filed proxies will be counted as present and will be voted as instructed on the matters listed in the notice for today's meeting. Stockholders intending to vote at the meeting rather than by proxy must do so via the online portal. Any stockholder who hasn't yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. For Proposal One, the affirmative vote of the holders of a plurality of the shares represented in person or by proxy, as required for the election of directors. The nine director nominees receiving the greatest number of votes cast will be elected as directors of the company. Proposal Two, approval of the compensation of the named executive officers. Proposal Three, the ratification of the selection of our independent registered public accounting firm will each pass if each proposal receives a majority of the votes cast with respect to the matter. Ms. Freedman has been appointed to rule on parliamentary matters and has been appointed to act as the Inspector of Elections. Now I would like to call upon the Secretary to report on the presence of a quorum. Mr. Gillheeney, as of the close of business on April 23rd, 2026, there were a total of 167,144,907 shares of the company's Class A common stock entitled to vote at this meeting, consisting of 128,674,548 outstanding shares of our Class A common stock and 38,470,359 shares of our Class A common stock issuable upon conversion of the Series A convertible preferred stock. The Series A convertible preferred stock votes with our Class A common stock on an as-converted basis. Holders of record of a majority in voting power of the shares entitled to vote are present in person or represented by proxy at this meeting, constituting a quorum for the transaction of business. The list of our registered stockholders as of the close of business on April 23rd, 2026, is available for inspection by stockholders during the meeting using the link available on the virtual meeting portal. The list, which was prepared by the company's transfer agent, Continental Stock Transfer & Trust Company, shows the name and address of each stockholder as of the record date of this meeting and the number of shares held. No stockholder has given the company notice of any other matter to be brought before this meeting in accordance with the procedures set forth in the company's bylaws. The only matters that will be voted upon are the items listed in the notice for today's meeting. The first order of business is the election of directors. Our directors serve for one-year terms. The board of directors have nominated Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf, and Gilberto Quintero for re-election as directors to serve until the next annual meeting of stockholders. Subsequently, concurrent with this meeting, we also expect that Garrett Lustig will be re-elected to the board as a preferred director upon the affirmative vote of the holders of our Series A convertible preferred stock, resulting in a total of 10 directors. No other person has been nominated by the stockholders to serve as a director of the company. I declare the nominations closed I will now entertain a motion that each of the nine nominees be elected as a director of the company to serve until the 2027 annual meeting of stockholders and until their respective successors have been elected and qualified. I so move. I second the motion. We will now proceed to a vote. I request that all those voting at this meeting for the election of directors of the company, including those acting as proxies, please submit your vote now. Any stockholder who hasn't voted or wishes to change their vote may do so by using the voting button on the web portal and following the instructions there. Stockholders who have sent in proxies or voted via the internet prior to the meeting and do not wish to change their vote do not need to take any further action. We will report the results following the presentation of proposal three. The second order of business is the advisory vote to approve the compensation paid to our named executive officers. I will now entertain a motion to approve, on an advisory basis, the compensation paid to our named executive officers as described in our proxy statement accompanying the notice for this meeting. I so move. I second the motion. We will now proceed to a vote. I request that all those voting at this meeting for the advisory vote to approve the compensation paid to our named executive officers, including those acting as proxies, please submit your vote now. Any stockholder who hasn't yet voted or wishes to change their vote may do so by using the voting button on the web portal and following the instructions there. Stockholders who have sent in proxies or voted via the internet prior to the meeting and do not wish to change their vote do not need to take any further action. We will report the results following the presentation of proposal three. I'll now move to the final item of business, which is the ratification of the appointment of our auditors, RSM US LLP, which has been appointed by the audit committee of our board of directors to serve as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026, and to audit our financial statements for the fiscal year ending December 31st, 2026. The audit committee has recommended that the board of directors submit this matter to the company's stockholders as a matter of good corporate practice. Even if the appointment is ratified, the audit committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interest of the company and its stockholders. I will now entertain a motion that the appointment of RSM US LLP as independent registered public accounting firm for the fiscal year ending December 31st, 2026, be ratified. I so move. I second the motion. We will now proceed to a vote. I request that all those voting at this meeting for the ratification of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31st, 2026, including those acting as proxies, please submit your vote now. Any stockholder who hasn't yet voted or wishes to change their vote may do so by using the voting button on the web portal and following the instructions there. Stockholders who have sent in proxies or voted via the internet prior to the meeting and do not wish to change their vote do not need to take any further action. Now that everyone has had the opportunity to vote, I now declare the polls for the 2026 annual meeting of stockholders of Organogenesis Holdings Inc. closed. I understand that the vote tabulation has been completed. Ms. Freedman, would you please report the results? Mr. Gillheeney, a plurality of the votes properly cast on proposal 1 has been voted in favor of each of Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney, Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf, and Gilberto Quintero for re-election as a director. In addition, a majority of the votes properly cast on proposal 2 has been voted to approve the compensation of the named executive officers. The majority of the votes properly cast on proposal 3 has been voted to ratify the appointment of RSM US LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. Thank you. I declare that the motions have carried and that the director nominees have been re-elected, the compensation paid to our named executive officers has been approved, and the appointment of RSM US LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026, have been duly ratified. This completes the formal part of our meeting. Since there are no further business to come before the meeting, I will entertain a motion for adjournment. I so move. I second the motion. It has been duly moved and seconded that the meeting be adjourned. All those in favor will please say, "Aye. Aye. Opposed? Aye. Opposed, nay. The motion has been carried. I declare this 2026 annual meeting of stockholders of Organogenesis Holdings Inc. adjourned. Now we would like to open things up for our stockholder questions and comments. If you have any questions that you have not previously submitted, please do so now. We ask that stockholders please identify themselves by name before asking their question. It looks like there are no questions at this time. Should you have any further questions after today's meetings, please feel free to email our investor relations contact through our website. On behalf of Organogenesis, our board of directors, and management team, I'd like to thank you for attending the 2026 Annual Stockholders' Meeting. That concludes our meeting today. You may now disconnect.